greeksoup/ stock research
Stock research / United States / HALO / Planned sales

Halozyme Therapeutics, Inc. planned insider sales

In the twelve months since 9 October 2025 insiders at Halozyme Therapeutics, Inc. filed 12 Form 144 notices of planned sales, 627,213 shares worth $53.4 million at the time of filing, from 6 sellers. The latest, filed 16 September 2026: Matthew Posard (director), 34,226 shares worth $3.6 million, planned for around 16 September 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleBrokerHow acquiredFiling
16 September 2026Matthew PosardDirector34,226$3.6 million16 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
17 August 2026Helen TorleyPresident, CEO, Director240,000$23.7 million17 August 2026J.P. Morgan Securities LLCStock Option ExerciseForm 144
11 August 2026Cortney A CaudillOfficer41,702$4.3 million11 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
10 August 2026Bernadette ConnaughtonDirector1,626$167,67310 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
29 June 2026Mahesh KrishnanDirector7,304$547,50829 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
15 May 2026Nicole LabrosseFormer Officer14,700$986,59215 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted stock vesting under a registered planForm 144
11 May 2026Helen TorleyPresident, CEO, Director101,923$6.5 million11 May 2026J.P. Morgan Securities LLCStock Option ExerciseForm 144
1 May 2026Bernadette ConnaughtonDirector4,875$310,3421 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
10 March 2026Cortney A CaudillOfficer8,857$599,08810 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered plan; Restricted stock vesting under a registered planForm 144
9 March 2026Cortney A CaudillOfficer20,000$1.4 million9 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
3 February 2026Helen TorleyPresident, CEO, Director150,000$11.2 million3 February 2026J.P. Morgan Securities LLCStock Option ExerciseForm 144
5 January 2026Bernadette ConnaughtonDirector2,000$140,6205 January 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.

Source

Form 144 filings on EDGAR for Halozyme Therapeutics, Inc.: the company's filing index, each notice read from its own XML.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install